Further, the conjugation of anti-STEAP1 antibodies with monomethyl auristatin E, a potent antimitotic agent, has shown potential in reducing tumor volume and delaying castration-resistant PCa [16,17,18]. The gene discussed is STEAP1; the disease is posterior cortical atrophy.